Shenzhen JYMed Technology Co., Ltd.

Shenzhen Jianxiang Biotechnology (JYMed/Jianyuan Pharmaceutical) is a CDMO enterprise specializing in polypeptides, providing polypeptide API R&D and GMP production from milligrams to tons. With 13 cGMP production lines and 85,000 L spps/LPPS reactor volumes, the Hubei base has an annual production capacity of 10 + tons and has passed FDA, NMPA, and EDQM inspections. Employees of 650 + are located in Shenzhen (7,000 ㎡ R&D center), Hubei (52,000 ㎡ API production base, OEB-5 isolation), and Shenzhen (formulation FDF base). Services cover custom synthesis, polypeptide API manufacturing (long chain, unnatural amino acids, conjugates), cosmetics/veterinary drugs/health peptides and CDMO, supporting 1 g R&D to 100 kg commercial batches. With 20 + years of experience in peptide chemistry and CDMO, we provide peptide intermediates, APIs and CDMO services to pharmaceutical companies worldwide.

Shenzhen JYMed Technology Co., Ltd. is located at No. 14, Kengzi Street Daojinhui Road Shengwuyiyaochuangxinyuanhaolou, Pingshan District, Shenzhen, China.

Main peptides produced: Cagrilintide, Tirzepatide, Retatrutide, Semaglutide, Liraglutide.

Finished peptide dosage forms available.

Website: https://www.jymedtech.com